NEW YORK: Fountain Healthcare Partners (“Fountain”) has announced the initial closing of its second fund, Fountain Healthcare Partners Fund II, L.P. with €85 million of committed capital.
The fund is a dedicated life science venture capital (“VC”) fund and brings Fountain’s total capital under management to €158 million. Within the life science sector, Fund II will primarily focus on specialty pharmaceuticals, biotechnology, medical devices and diagnostics.
Fountain will invest over 75% of its capital in Europe with the balance in the US market. Having exceeded its initial close target, Fountain is now seeking additional investors to close Fund II with a hard cap of €125 million…